ArticlePopulation health metrics2026
Towards a burden of disease research agenda.
Article in Population health metrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Disability-Adjusted Life Years (DALY) have become a common metric for assessing the combined effects of morbidity and mortality. However, the lack of resources and/or input data, combined with the complexity of the methodological framework, resulted in major disparities in research capacity and knowledge about burden of disease estimations across Europe. Since 2019, the European Burden of Disease (burden-eu) Network has been acting as a technical platform for strengthening capacity in burden of disease assessments. The burden-eu network developed a forward-looking research agenda, identifying four key burden of disease themes: transparency and availability, method refinement, potential expansions, and specific topics. The research agenda's priorities can be used to prioritise and guide the design of studies in the burden of disease framework.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.